I completely agree with you Junebug. The MariMed relationship certainly could have benefit, and I have posted about the Vitiprint technology that could be ideal if used for the Univec transdermal patch. I think that kind of relationship would be a win, win if it turns out to be true. And, make no mistake about it, the potential increase in value would be huge. I hope it does prove out. My point is that we need verification, and sooner rather than later. Keeping everything secrete works well for a while, but then begins to work against everyone, and that includes the company. The Merck tie-in is another huge deal, and could propel this tiny stock to the stratosphere --- again, if it proves out. I have not sold a single share, and it is the potential that keeps me hanging on here. But I would like some kind of timeline, because as you know I am not getting any younger. That is all I am saying. Are we talking a day, a week, three months, six months, a year....